María Izco Gaviria

María Izco Gaviria

Email: mizco@riojasalud.es

Phone: +34 941 278 791 (Ext.:89791)

Biosketch

María Izco graduated in Biochemistry from the University of Zaragoza (2003) and received her Ph.D. in Pharmacology and Human Therapeutics (PhD Studentship from the Universidad Complutense, PhD Studentship from the Government of Madrid) from the Complutense University of Madrid in 2008, obtaining also the Extraordinary Prize of Thesis. During her thesis, she worked on the study of the mechanisms involved in hyperthermia and neurodegeneration induced by MDMA (ecstasy) in rodents as well as on the study of neurochemical and behavioral interactions between MDMA and other drugs commonly used, such as ethanol, in rodents.

In 2008 she was appointed as postdoctoral researcher in the pharmaceutical company Araclon Biotech-Grifols as (2008-2015). During this period, she participated in a project focused on immunotherapy and its mechanisms of action in animal models of Alzheimer’s disease.

In 2015 she joined the CIBIR as a postdoctoral researcher in the Molecular Neurobiology group of Dr. Alvarez-Erviti. Our research projects focus on the pathological mechanisms involved in Parkinson’s disease and the role of alpha-synuclein in the pathology. Moreover, we are developing a gene therapy treatment the Parkinson's disease.

Publications